
|Articles|November 1, 2003
Eyetech plans IPO of shares of common stock
New York-Eyetech Pharmaceuticals plans to extend an initial public offering of shares of its common stock.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope Therapeutics releases positive 3-year follow-up data from REMAIN study
2
FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment
3
Development of maculopathy associated with systemic medications
4
Proactive strategies and sustained delivery advance glaucoma care
5

















































.png)


